Eleven Biotherapeutics

Investor FAQs
 

The Eleven Biotherapeutics, Inc. ticker is EBIO and it is traded on The NASDAQ Global Market.

February 6, 2014

215 First Street, Suite 400
Cambridge, MA 02142

You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.

You can view our management team by visiting the Management section of our Investor Relations website.

December 31

Ernst & Young, LLP

Eleven Biotherapeutics, Inc. does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.

Eleven Biotherapeutics, Inc. does not currently have a direct stock purchase plan.

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financials & Filings portion of our Investor Relations website or directly from the SEC at www.sec.gov.

You can contact Eleven Biotherapeutics, Inc. Investor Relations via email at: leah.monteiro@elevenbio.com

Please submit your question using the form below.

* Indicates required field
NASDAQ: EBIO
Price:
1.95
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on February 24, 2017
Delayed at least 20 minutes.